Comparison of Ceftolozane/Tazobactam Infusion Regimens in a Hollow-Fiber Infection Model against Extensively Drug-Resistant Pseudomonas aeruginosa Isolates
MM Montero, S Domene-Ochoa… - Microbiology …, 2022 - Am Soc Microbiol
The aim of this study was to compare the efficacy of intermittent (1-h), extended (4-h), and
continuous ceftolozane-tazobactam (C/T) infusion against three extensively drug-resistant …
continuous ceftolozane-tazobactam (C/T) infusion against three extensively drug-resistant …
Comparison of Ceftolozane/Tazobactam Infusion Regimens in a Hollow-Fiber Infection Model against Extensively Drug-Resistant Isolates
MM Montero - 2022 - ddd.uab.cat
The aim of this study was to compare the efficacy of intermittent (1-h), extended (4-h), and
continuous ceftolozane-tazobactam (C/T) infusion against three extensively drug-resistant …
continuous ceftolozane-tazobactam (C/T) infusion against three extensively drug-resistant …
Comparison of Ceftolozane/Tazobactam Infusion Regimens in a Hollow-Fiber Infection Model against Extensively Drug-Resistant Pseudomonas aeruginosa Isolates
MM Montero, S Domene-Ochoa… - Microbiology …, 2022 - pubmed.ncbi.nlm.nih.gov
The aim of this study was to compare the efficacy of intermittent (1-h), extended (4-h), and
continuous ceftolozane-tazobactam (C/T) infusion against three extensively drug-resistant …
continuous ceftolozane-tazobactam (C/T) infusion against three extensively drug-resistant …
[引用][C] Comparison of ceftolozane/tazobactam infusion regimens in a hollow-fiber infection model against extensively drug-resistant Pseudomonas aeruginosa isolates
MM Montero, S Domene-Ochoa… - Microbiology …, 2022 - espace.library.uq.edu.au
The aim of this study was to compare the efficacy of intermittent (1-h), extended (4-h), and
continuous ceftolozane-tazobactam (C/T) infusion against three extensively drug-resistant …
continuous ceftolozane-tazobactam (C/T) infusion against three extensively drug-resistant …
[HTML][HTML] Comparison of Ceftolozane/Tazobactam Infusion Regimens in a Hollow-Fiber Infection Model against Extensively Drug-Resistant Pseudomonas aeruginosa …
MM Montero, S Domene-Ochoa… - Microbiology …, 2022 - ncbi.nlm.nih.gov
The aim of this study was to compare the efficacy of intermittent (1-h), extended (4-h), and
continuous ceftolozane-tazobactam (C/T) infusion against three extensively drug-resistant …
continuous ceftolozane-tazobactam (C/T) infusion against three extensively drug-resistant …
Comparison of Ceftolozane/Tazobactam Infusion Regimens in a Hollow-Fiber Infection Model against Extensively Drug-Resistant Pseudomonas aeruginosa Isolates
MM Montero, S Domene-Ochoa, C López-Causapé… - 2022 - agris.fao.org
The aim of this study was to compare the efficacy of intermittent (1-h), extended (4-h), and
continuous ceftolozane-tazobactam (C/T) infusion against three extensively drug-resistant …
continuous ceftolozane-tazobactam (C/T) infusion against three extensively drug-resistant …
Comparison of ceftolozane/tazobactam infusion regimens in a hollow-fiber infection model against extensively drug-resistant Pseudomonas aeruginosa isolates.
M Milagro Montero, S Domene-Ochoa… - 2022 - cabidigitallibrary.org
The aim of this study was to compare the efficacy of intermittent (1-h), extended (4-h), and
continuous ceftolozane-tazobactam (C/T) infusion against three extensively drug-resistant …
continuous ceftolozane-tazobactam (C/T) infusion against three extensively drug-resistant …
Comparison of Ceftolozane/Tazobactam infusion regimens in a hollow-fiber infection model against extensively drug-resistant pseudomonas aeruginosa isolates
MM Montero, S Domene Ochoa, C López-Causapé… - 2022 - repositori.upf.edu
The aim of this study was to compare the efficacy of intermittent (1-h), extended (4-h), and
continuous ceftolozane-tazobactam (C/T) infusion against three extensively drug-resistant …
continuous ceftolozane-tazobactam (C/T) infusion against three extensively drug-resistant …
Comparison of Ceftolozane/Tazobactam Infusion Regimens in a Hollow-Fiber Infection Model against Extensively Drug-Resistant Pseudomonas aeruginosa Isolates.
MM Montero, S Domene-Ochoa… - Microbiology …, 2022 - europepmc.org
The aim of this study was to compare the efficacy of intermittent (1-h), extended (4-h), and
continuous ceftolozane-tazobactam (C/T) infusion against three extensively drug-resistant …
continuous ceftolozane-tazobactam (C/T) infusion against three extensively drug-resistant …
Comparison of Ceftolozane/Tazobactam Infusion Regimens in a Hollow-Fiber Infection Model against Extensively Drug-Resistant Pseudomonas aeruginosa Isolates
MM Montero, S Domene-Ochoa… - Microbiology …, 2022 - docusalut.com
The aim of this study was to compare the efficacy of intermittent (1-h), extended (4-h), and
continuous ceftolozane-tazobactam (C/T) infusion against three extensively drug-resistant …
continuous ceftolozane-tazobactam (C/T) infusion against three extensively drug-resistant …